BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24524051)

  • 21. The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea.
    Choi JA; Song LD; Choi S; Park SM; Kwon JW; Jee D
    Medicine (Baltimore); 2019 Jan; 98(2):e14026. PubMed ID: 30633194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of use and cost of medical care of common lumbar disorders in Korea: cross-sectional study of Korean Health Insurance Review and Assessment Service National Patient Sample data.
    Ahn YJ; Shin JS; Lee J; Lee YJ; Kim MR; Park KB; Lee JH; Shin KM; Ha IH
    BMJ Open; 2016 Sep; 6(9):e012432. PubMed ID: 27619830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older.
    Koo JS; Moon SH; Lee H; Park S; Yu YM; Kang HY
    PLoS One; 2020; 15(12):e0244759. PubMed ID: 33382798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early results of pediatric appendicitis after adoption of diagnosis-related group-based payment system in South Korea.
    Moon SB
    J Multidiscip Healthc; 2015; 8():503-9. PubMed ID: 26648734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Projection of osteoporosis-related fractures and costs in China: 2010-2050.
    Si L; Winzenberg TM; Jiang Q; Chen M; Palmer AJ
    Osteoporos Int; 2015 Jul; 26(7):1929-37. PubMed ID: 25761729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Socioeconomic costs of overactive bladder and stress urinary incontinence in Korea.
    Sung W; You H; Yoon TY; Lee SJ
    Int Neurourol J; 2012 Mar; 16(1):23-9. PubMed ID: 22500250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healthcare Costs of Osteoporotic Fracture in Korea: Information from the National Health Insurance Claims Database, 2008-2011.
    Kim HY; Ha YC; Kim TY; Cho H; Lee YK; Baek JY; Jang S
    J Bone Metab; 2017 May; 24(2):125-133. PubMed ID: 28642857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The burden of osteoporosis in Saudi Arabia: a scorecard and economic model.
    Aziziyeh R; Garcia Perlaza J; Saleem N; Sadat-Ali M; Elsalmawy A; McTavish RK; Duperrouzel C; Cameron C
    J Med Econ; 2020 Jul; 23(7):767-775. PubMed ID: 32122190
    [No Abstract]   [Full Text] [Related]  

  • 29. The Cost of Osteoporosis, Osteopenia, and Associated Fractures in Australia in 2017.
    Tatangelo G; Watts J; Lim K; Connaughton C; Abimanyi-Ochom J; Borgström F; Nicholson GC; Shore-Lorenti C; Stuart AL; Iuliano-Burns S; Seeman E; Prince R; March L; Cross M; Winzenberg T; Laslett LL; Duque G; Ebeling PR; Sanders KM
    J Bone Miner Res; 2019 Apr; 34(4):616-625. PubMed ID: 30615801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of Osteoporosis & Osteoporotic Fractures in Korea Based on Health Insurance Review and Assessment (HIRA) Database: 2009-2017.
    Oh HS; Kim SK; Seo HY
    Healthcare (Basel); 2021 Mar; 9(3):. PubMed ID: 33799330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.
    Moriwaki K; Fukuda H
    Osteoporos Int; 2019 Feb; 30(2):299-310. PubMed ID: 30610244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A health economic simulation model for the clinical management of osteoporosis.
    Jonsson E; Hansson-Hedblom A; Ljunggren Ö; Åkesson K; Spångeus A; Kanis JA; Borgström F
    Osteoporos Int; 2018 Mar; 29(3):545-555. PubMed ID: 29196775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study.
    Kim SC; Kim MS; Sanfélix-Gimeno G; Song HJ; Liu J; Hurtado I; Peiró S; Lee J; Choi NK; Park BJ; Avorn J
    Am J Med; 2015 May; 128(5):519-26.e1. PubMed ID: 25660252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy.
    Viswanathan HN; Curtis JR; Yu J; White J; Stolshek BS; Merinar C; Balasubramanian A; Kallich JD; Adams JL; Wade SW
    Appl Health Econ Health Policy; 2012 May; 10(3):163-73. PubMed ID: 22510025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial.
    Majumdar SR; Johnson JA; Lier DA; Russell AS; Hanley DA; Blitz S; Steiner IP; Maksymowych WP; Morrish DW; Holroyd BR; Rowe BH
    Osteoporos Int; 2007 Mar; 18(3):261-70. PubMed ID: 17086470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of Patients Diagnosed with Osteoporosis in South Korea: Results from the National Claim Registry.
    Yoon HK; Lee YK; Ha YC
    J Bone Metab; 2017 Feb; 24(1):59-63. PubMed ID: 28326302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gaps in universal health coverage in South Korea: Association with depression onset in a community cohort.
    Park HY; Hong YC; Kawachi I; Oh J
    PLoS One; 2018; 13(6):e0197679. PubMed ID: 29889833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare Resource Utilization and Direct Medical Costs for Patients With Osteoporotic Fractures in China.
    Wu J; Qu Y; Wang K; Chen Y
    Value Health Reg Issues; 2019 May; 18():106-111. PubMed ID: 30909083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current economic burden of illness of osteoporosis in Canada.
    Hopkins RB; Burke N; Von Keyserlingk C; Leslie WD; Morin SN; Adachi JD; Papaioannou A; Bessette L; Brown JP; Pericleous L; Tarride J
    Osteoporos Int; 2016 Oct; 27(10):3023-32. PubMed ID: 27166680
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.